PROFILE OF COLIFORM STRAINS’ ANTIBIOTIC RESISTANCE
PDF

How to Cite

ჩიკვილაძე დ. C. D., გაჩეჩილაძე ხ. G. K., მიქელაძე მ. M. M., & Metreveli D. მ. დ. (2019). PROFILE OF COLIFORM STRAINS’ ANTIBIOTIC RESISTANCE. Collection of Scientific Works of Tbilisi State Medical University, 49, 135–157. https://doi.org/10.52340/csw.2015.49.0.135-157

Abstract

 

The spectrum of sensitivity of 112 E. coli strains isolated from patients with acute intestinal infection to 23 antibiotics was investigated  by the agar dilution method, which revealed an increase in drug resistance and the emergence of multidrug-resistant strains  (33.04%). It was found that the drug resistance of the pathogen to nalidixic acid and carbopenems increased and its high sensitivity to some ftuoroquinolones, III and IV generation aminoglycosides, penicillins and cephalosporins preserved. The drug resistance in future may lead to the formation of hospital strains among E. coli and alter an epidemiological process and the clinical course of the disease.

https://doi.org/10.52340/csw.2015.49.0.135-157
PDF

References

1. Основы инфекционного контроля: Практи¬ческое руководство - Американский между¬народный союз здравоохранения., М. Альпина Паблишер, 2003. - 478 с.
2. მჭედლიშვილი ი. _ ინფექციურ დაავადებათა ეპიდემიოლოგია. ნაწილი II. თბილისი 2006, 16-17
3. Бондаренко В.М., Грачёв Н.Н., Мацулевич Т.В. - Дисбактериоз кишечника // М. Медицина, 2009, -894. Talen D., Vorgan G., Newdow M. Etiology of bloody diarrhea among patients presenting to United States emergensy departments prevalence of Escherichia coli O157:H7 and other enteropathogens // Clin. Infect. Dis. 2011, 32, 573-580
5. Sheikh N., Tarr P. - Escherichia coli O157:H7 Shigatoxin - enloding bacteriophages: interationary implications / /J. Bacteriol. 2013, 185(2), 3596-3605
6. Antibiotic resistance threats in the United States 2013. htt://www.cdc.gov/drugresistance/pdf/ar-treats-2013-508 pdf
7. კერესელიძე მ. “კლინიკური ბაქტერიოლოგია” _ მეთოდური სახელმძღვანელო-ცნობარი, თბილისი, 2013, -259

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...